UCSF scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson’s to cancer and have long been thought to be “undruggable.” UCSF scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson’s to cancer and have long been thought to be “undruggable.” Cell & Microbiology Molecular & Computational biology Phys.org – latest science and technology news stories
Scientists learn how to drug wily class of disease-causing enzymes
